ArticleInternational urology and nephrology2025

A clinical study of RC48-ADC combined with PD-1 inhibitor in bladder preservation therapy for muscle-invasive bladder cancer (MIBC)-based on real-world data analysis.

Shaolong Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.